Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Net Cash Flow (2016 - 2025)

Firefly Neuroscience has reported Net Cash Flow over the past 15 years, most recently at -$1.6 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$1.6 million for Q4 2025, down 372.07% from a year ago — trailing twelve months through Dec 2025 was $937000.0 (up 381.38% YoY), and the annual figure for FY2025 was $937000.0, up 381.38%.
  • Net Cash Flow for Q4 2025 was -$1.6 million at Firefly Neuroscience, up from -$1.6 million in the prior quarter.
  • Over the last five years, Net Cash Flow for AIFF hit a ceiling of $7.7 million in Q1 2025 and a floor of -$3.6 million in Q2 2025.
  • Median Net Cash Flow over the past 5 years was -$196390.5 (2023), compared with a mean of -$5439.6.
  • Biggest five-year swings in Net Cash Flow: crashed 703.77% in 2024 and later skyrocketed 1631.68% in 2025.
  • Firefly Neuroscience's Net Cash Flow stood at $1.2 million in 2021, then tumbled by 297.11% to -$2.5 million in 2022, then skyrocketed by 150.79% to $1.2 million in 2023, then plummeted by 53.6% to $580000.0 in 2024, then tumbled by 372.07% to -$1.6 million in 2025.
  • The last three reported values for Net Cash Flow were -$1.6 million (Q4 2025), -$1.6 million (Q3 2025), and -$3.6 million (Q2 2025) per Business Quant data.